The Discounted Cash Flow (DCF) valuation of Kaken Pharmaceutical Co Ltd (4521.T) is 6,186.82 JPY. With the latest stock price at 3,775.00 JPY, the upside of Kaken Pharmaceutical Co Ltd based on DCF is 63.9%.
Based on the latest price of 3,775.00 JPY and our DCF valuation, Kaken Pharmaceutical Co Ltd (4521.T) is a buy. buying 4521.T stocks now will result in a potential gain of 63.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.8% | 6.6% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 5,257.36 - 7,816.53 | 6,186.82 |
| Upside | 39.3% - 107.1% | 63.9% |